LDHA and Hepatic fibrosis: In conclusion, gypenoside improved histopathological changes of hepatic dysfunction in CCl4-induced liver fibrosis rats, and the pharmacological effect of inhibiting fibrosis may be involved in the alteration of glycolysis metabolism and the protection against the damage of aldehydes and LPO by up-regulating ALDH.